−1.80 TWD
−45.24 M TWD
13.67 M TWD
About DUOGENIC STEMCELLS CORP
Sector
Industry
CEO
Chih Yao Lin
Website
Headquarters
Taichung
Founded
2018
ISIN
TW0007607004
FIGI
BBG012DRSSF2
Duogenic Stemcells Corp. engages in the provision of biotechnology and medical care services. It offers closed culture cell system and cell therapy services. The company was founded on March 22, 2018 and is headquartered in Taichung, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7607 is 23.00 TWD — it has decreased by −0.22% in the past 24 hours. Watch DUOGENIC STEMCELLS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange DUOGENIC STEMCELLS CORP stocks are traded under the ticker 7607.
7607 stock has fallen by −6.12% compared to the previous week, the month change is a −20.42% fall, over the last year DUOGENIC STEMCELLS CORP has showed a −36.11% decrease.
7607 reached its all-time high on May 25, 2023 with the price of 65.10 TWD, and its all-time low was 23.75 TWD and was reached on Dec 19, 2024. View more price dynamics on 7607 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7607 stock is 0.22% volatile and has beta coefficient of −0.13. Track DUOGENIC STEMCELLS CORP stock price on the chart and check out the list of the most volatile stocks — is DUOGENIC STEMCELLS CORP there?
Yes, you can track DUOGENIC STEMCELLS CORP financials in yearly and quarterly reports right on TradingView.
7607 net income for the last half-year is −32.30 M TWD, while the previous report showed −23.27 M TWD of net income which accounts for −38.81% change. Track more DUOGENIC STEMCELLS CORP financial stats to get the full picture.
No, 7607 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DUOGENIC STEMCELLS CORP EBITDA is −48.55 M TWD, and current EBITDA margin is −277.11%. See more stats in DUOGENIC STEMCELLS CORP financial statements.
Like other stocks, 7607 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DUOGENIC STEMCELLS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DUOGENIC STEMCELLS CORP technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DUOGENIC STEMCELLS CORP stock shows the strong sell signal. See more of DUOGENIC STEMCELLS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.